Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Ongoing clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events, no viral rebounds to date and faster time to sustained symptom resolution;...
-
EAU CLAIRE, Wis., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Citizens Community Bancorp, Inc. (the “Company”) (Nasdaq: CZWI), the parent company of Citizens Community Federal N.A. (the “Bank” or “CCFBank”),...
-
PASADENA, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- The power of artificial intelligence (AI) and advanced computing has made it possible to design genetic sequences encoding for diverse biological...
-
Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Edutainment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's...
-
UNIONDALE, NY, Jan. 26, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and consumer products company, today provided an...
-
VANCOUVER, BC, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Fobi AI Inc. (TSXV:FOBI) (Pink: FOBIF) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital...
-
TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on Nasdaq: NASDAQ: MRM, hereinafter...
-
OCALA, Fla., Jan. 23, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and...
-
CHICAGO, IL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- As January marks Mental Wellness Month, experts at The Neurologic Wellness Institute are spotlighting neurofeedback therapy as an evidence-based...
-
Record Q3 Fiscal 2026 Results Expected Revenue of $15.3M - $15.5M+ and Adjusted EBITDA* of $1.8M- $ 2.3M+ (350%+ YOY) Record Nine Months Ended December 31, 2025 Results Expected Revenue of $45M...